Lifemd Inc

LifeMD to Report First Quarter 2026 Financial Results on May 6

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

LifeMD Reports Fourth Quarter and Full Year 2025 Results